HC Wainwright & Co. Maintains Buy on Milestone Pharmaceuticals, Raises Price Target to $8

Benzinga · 2d ago
HC Wainwright & Co. analyst Brandon Folkes maintains Milestone Pharmaceuticals (NASDAQ:MIST) with a Buy and raises the price target from $5 to $8.